Radiology artificial intelligence (AI) startup Rad AI has garnered $25 million in a series A funding round.
Led by Artis Ventures, the financing round also included participation from several existing investors, including OCV Partners, Kickstart Fund, and Google's AI-focused fund Gradient Ventures, according to Rad AI.
The company said it would use the funds to further develop and commercialize its Omni and Continuity offerings. Omni is designed to save radiologists 60 or more minutes a day by automatically generating the "impression" section of the radiology report based on the dictated findings, Rad AI said.
Geared toward health systems, Continuity automatically identifies follow-up recommendations for a wide range of incidental findings, assesses clinical appropriateness based on national consensus guidelines and health system requirements, and specifically tracks appropriate follow-ups, according to the vendor.
![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
